These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 17187196

  • 1. Postural stabilizing effect of alfacalcidol and active absorbable algal calcium (AAA Ca) compared with calcium carbonate assessed by computerized posturography.
    Fujita T, Nakamura S, Ohue M, Fujii Y, Miyauchi A, Takagi Y, Tsugeno H.
    J Bone Miner Metab; 2007; 25(1):68-73. PubMed ID: 17187196
    [Abstract] [Full Text] [Related]

  • 2. Superiority of alfacalcidol compared to vitamin D plus calcium in lumbar bone mineral density in postmenopausal osteoporosis.
    Nuti R, Bianchi G, Brandi ML, Caudarella R, D'Erasmo E, Fiore C, Isaia GC, Luisetto G, Muratore M, Oriente P, Ortolani S.
    Rheumatol Int; 2006 Mar; 26(5):445-53. PubMed ID: 16283320
    [Abstract] [Full Text] [Related]

  • 3. Reappraisal of Katsuragi calcium study, a prospective, double-blind, placebo-controlled study of the effect of active absorbable algal calcium (AAACa) on vertebral deformity and fracture.
    Fujita T, Ohue M, Fujii Y, Miyauchi A, Takagi Y.
    J Bone Miner Metab; 2004 Mar; 22(1):32-8. PubMed ID: 14691684
    [Abstract] [Full Text] [Related]

  • 4. Superiority of a combined treatment of Alendronate and Alfacalcidol compared to the combination of Alendronate and plain vitamin D or Alfacalcidol alone in established postmenopausal or male osteoporosis (AAC-Trial).
    Ringe JD, Farahmand P, Schacht E, Rozehnal A.
    Rheumatol Int; 2007 Mar; 27(5):425-34. PubMed ID: 17216477
    [Abstract] [Full Text] [Related]

  • 5. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis.
    Ringe JD, Faber H, Fahramand P, Schacht E.
    J Rheumatol Suppl; 2005 Sep; 76():33-40. PubMed ID: 16142849
    [Abstract] [Full Text] [Related]

  • 6. Effect of age on body sway assessed by computerized posturography.
    Fujita T, Nakamura S, Ohue M, Fujii Y, Miyauchi A, Takagi Y, Tsugeno H.
    J Bone Miner Metab; 2005 Sep; 23(2):152-6. PubMed ID: 15750694
    [Abstract] [Full Text] [Related]

  • 7. Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis.
    Ringe JD, Dorst A, Faber H, Schacht E, Rahlfs VW.
    Rheumatol Int; 2004 Mar; 24(2):63-70. PubMed ID: 14513268
    [Abstract] [Full Text] [Related]

  • 8. [Prevention of glucocorticoid-induced osteoporosis in patients with primary glomerulonephritis].
    Chen H, Wang M.
    Zhonghua Yi Xue Za Zhi; 2005 Aug 17; 85(31):2207-10. PubMed ID: 16321186
    [Abstract] [Full Text] [Related]

  • 9. Importance of alfacalcidol in clinical conditions characterized by high rate of bone loss.
    Reginster JY, Lecart MP, Richy F.
    J Rheumatol Suppl; 2005 Sep 17; 76():21-5. PubMed ID: 16142847
    [Abstract] [Full Text] [Related]

  • 10. Fall Prevention and Anti-Osteoporosis in Osteopenia Patients of 80 Years of Age and Older: A Randomized Controlled Study.
    Zhou J, Liu B, Qin MZ, Liu JP.
    Orthop Surg; 2020 Jun 17; 12(3):890-899. PubMed ID: 32495521
    [Abstract] [Full Text] [Related]

  • 11. Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis.
    Shiraki M, Fukuchi M, Kiriyama T, Okamoto S, Ueno T, Sakamoto H, Nagai T.
    J Bone Miner Metab; 2004 Jun 17; 22(4):352-9. PubMed ID: 15221494
    [Abstract] [Full Text] [Related]

  • 12. Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol.
    Fujita T, Orimo H, Inoue T, Kaneda K, Sakurai M, Morita R, Yamamoto K, Sugioka Y, Inoue A, Takaoka K, Yamamoto I, Hoshino Y, Kawaguchi H.
    J Bone Miner Metab; 2007 Jun 17; 25(2):130-7. PubMed ID: 17323183
    [Abstract] [Full Text] [Related]

  • 13. Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: relations of change in bone mineral density, bone markers, and calcium homeostasis.
    Jacobs JW, de Nijs RN, Lems WF, Geusens PP, Laan RF, Huisman AM, Algra A, Buskens E, Hofbauer LC, Oostveen AC, Bruyn GA, Dijkmans BA, Bijlsma JW.
    J Rheumatol; 2007 May 17; 34(5):1051-7. PubMed ID: 17407214
    [Abstract] [Full Text] [Related]

  • 14. [Clinical study on combination of multiple regimens in treatment of osteoporosis in perimenopause and postmenopausal women].
    Guan YT, Cai LL, Ding HX, Chen GD, Hu Y.
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug 17; 45(8):571-4. PubMed ID: 21029610
    [Abstract] [Full Text] [Related]

  • 15. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E, Lyritis GP, Kosmidis C, Galanos A, Andypas G, Chorianopoulos K, Giagiosis A, Iliadou K, Karagianis A, Katsimichas K, Koskinas A, Matsouka K.
    Clin Rheumatol; 2005 Jun 17; 24(3):232-8. PubMed ID: 15647969
    [Abstract] [Full Text] [Related]

  • 16. [Postmenopausal osteoporosis. Digital Rx radiogrammetry in the diagnosis and follow-up of treatment with alfacalcidol].
    Galeşanu C, Ciubotariu C, Melnic G, Galeşanu MR.
    Rev Med Chir Soc Med Nat Iasi; 2006 Jun 17; 110(4):833-41. PubMed ID: 17438884
    [Abstract] [Full Text] [Related]

  • 17. Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium.
    Ringe JD, Cöster A, Meng T, Schacht E, Umbach R.
    Calcif Tissue Int; 1999 Oct 17; 65(4):337-40. PubMed ID: 10485988
    [Abstract] [Full Text] [Related]

  • 18. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F, Schacht E, Bruyere O, Ethgen O, Gourlay M, Reginster JY.
    Calcif Tissue Int; 2005 Mar 17; 76(3):176-86. PubMed ID: 15692726
    [Abstract] [Full Text] [Related]

  • 19. Randomized controlled trial of alfacalcidol supplementation for the reduction of hypocalcemia after total thyroidectomy.
    Genser L, Trésallet C, Godiris-Petit G, Li Sun Fui S, Salepcioglu H, Royer C, Menegaux F.
    Am J Surg; 2014 Jan 17; 207(1):39-45. PubMed ID: 24119718
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the effects of eldecalcitol and alfacalcidol on bone and calcium metabolism.
    Matsumoto T, Takano T, Yamakido S, Takahashi F, Tsuji N.
    J Steroid Biochem Mol Biol; 2010 Jul 17; 121(1-2):261-4. PubMed ID: 20298784
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.